Navigation Links
Many Who Should Use Statins Don't
Date:4/25/2009

Survey finds lack of access to medical care a big factor in trend

SATURDAY, April 25 (HealthDay News) -- Nearly half of the Americans who meet the criteria for taking cholesterol-lowering statins aren't taking the drug, a national survey indicates.

"There is a definite gap between medical evidence and practice," said Dr. Erica S. Spatz, an internist in the Yale University Robert Wood Johnson Medical Scholar Program. She was to report the finding Saturday at an American Heart Association meeting in Washington, D.C.

Spatz and her colleagues used data from the 2003-2004 National Health and Nutrition Examination Survey to identify 777 adults who met the criteria set by the National Cholesterol Education Program for statin therapy. Those criteria consider not only blood levels of LDL cholesterol, the "bad" kind found in artery-clogging plaques (in general, a reading below 100 milligrams per deciliter is recommended), but also other risk factors for cardiovascular disease, such as smoking, obesity and high blood pressure.

jUST 428 of those individuals were taking cholesterol-lowering drugs, the survey found. Overall, 44.9 percent of the people who met the criteria for cholesterol-lowering drug treatment were untreated, Spatz reported.

Major factors associated with being untreated were:

  • Being younger than 50 -- twice as likely to be untreated.
  • Not having health insurance -- more than twice as likely to be untreated.
  • Not having a source of regular medical care -- nearly four times as likely to be untreated.
  • Having untreated or undiagnosed diabetes -- more than six times as likely to be untreated.

People who reported being told they had high cholesterol and who had a history of heart disease were more likely to be taking the medications.

"The most interesting finding from our study is that lack of health insurance is certainly predictive," Spatz said. "The cost of medication is sometimes prohibitive."

But not having a regular source of medical care is an even more important indicator, she said.

The factors related to high cholesterol tend to be interlocking, Spatz said. "High blood cholesterol is associated with other co-morbidities, such as high blood pressure and diabetes," she said. "These people often are underdiagnosed for those conditions, which reinforces the need for access to medical care."

Even though a problem has been identified, "there is no simple solution to this," Spatz said. "We need to address the reasons why there is poor access to medical care for people with insurance."

The study shows the need for adherence to the guidelines for statin therapy, said Dr. Gregg Fonarow, a professor of medicine at the University of California, Los Angeles, and a spokesman for the American Heart Association.

"Those guidelines are based on randomized clinical trials which show that statin therapy lowers the risk of myocardial infarction [heart attack] and stroke for eligible patients," Fonarow said. "More needs to be done to implement the current guidelines."

Drug therapy is not the only measure to be taken against high cholesterol, he said. "Lifestyle modifications and medications are both appropriate measures," he said. "This is a very serious issue that requires much more attention and focused efforts."

More information

Learn what you need to know about high cholesterol from the National Cholesterol Education Program.



SOURCES: Erica S. Spatz, M.D., Robert Wood Johnson Medical Scholar, Yale University, New Haven, Conn.; Gregg Fonarow, M.D, professor, medicine, University of California, Los Angeles; April 25, 2009, presentation, American Heart Association 10th Scientific Forum on Care and Outcomes Research in Cardiovascular Disease and Stroke, Washington, D.C.


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Health-care reform should start with paying evidence-based financial incentives to doctors
2. She Works Hard for the Money, so She Shouldnt Have to Work Hard for Great Skin
3. Jobless Should Evaluate COBRA, Medicare in Light of 2009 Recovery Act
4. Egg Donor Surge Makes Due Diligence Critical: 7 Questions Donors Should Ask
5. Prune juice not necessary: New research should make bowel movements easier
6. Western Orthopaedics in Denver Blends Innovative Techniques to Provide a Spectrum of Shoulder Care
7. Healing a shoulder separation
8. Healing a Shoulder Separation
9. A New Number Everyone Should Know: Their PDQ
10. How Much Should Women Drink? It Depends on Who You Ask
11. Genetics Should Decide Warfarin Dose, Study Reiterates
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Many Who Should Use Statins Don't 
(Date:5/2/2016)... ... May 02, 2016 , ... Consultative health ... and GM Jim Callandrillo and Duane Reed, VP of business development of AJMC ... Intelligence and Research Group (PBIRG) General Meeting from May 15-17 at the ...
(Date:5/2/2016)... ... 2016 , ... Atlantic Information Services, Inc. (AIS) is pleased to announce its ... the Pharma Landscape .” CMS recently proposed a test of alternate payment models for ... preserving care provided to beneficiaries. The webinar will review the details of this model, ...
(Date:5/2/2016)... ... May 02, 2016 , ... For many artists, the act ... Walter has developed it into a science. , Using the new, highly precise ... differentiated shades that add depth and meaning to his works. What’s more, it has ...
(Date:5/2/2016)... ... 2016 , ... The debilitating disease of arthritis can bring patients a hefty ... must deal with prescription costs to treat arthritis over the course of a lifetime. ... the pharmacy on many common prescriptions. , Arthritis , Although arthritis is a very ...
(Date:5/2/2016)... ... May 02, 2016 , ... Summit BHC ... the opening of Twin Lakes Recovery Center. Located east of Atlanta in ... state. The residential facility is set on 34 acres of beautiful, secluded ...
Breaking Medicine News(10 mins):
(Date:4/29/2016)... , April 29, 2016 ... Review, H1 2016" market research report that provides ... with comparative analysis at various stages, therapeutics assessment ... of administration (RoA) and molecule type, along with ... It also reviews key players involved in the ...
(Date:4/29/2016)... April 29, 2016 Glycotope GmbH, ... today announces the appointment of Dr. Alfredo Zurlo ... is an oncologist with many years clinical experience and ... industries. His last role was at Mologen AG where ... Executive Board. Previously Dr. Zurlo held various positions at ...
(Date:4/28/2016)... April 28, 2016  While Abbott,s announced purchase ... company,s valve repair and stent business, healthcare research ... Abbott more firmly into patient monitoring.  Kalorama said ... growing device areas, with double-digit growth expected the ... Advanced Remote Patient Monitoring . Abbott ...
Breaking Medicine Technology: